Can I Take Glutathione with NMN or NR?

What Are NMN, NR, and Glutathione, and Why Do People Stack Them?

NMN and NR are two well-studied precursors to NAD+ (nicotinamide adenine dinucleotide), a coenzyme involved in energy metabolism, DNA repair, and cellular stress response. Glutathione is the body's most abundant intracellular antioxidant, a tripeptide (glycine, cysteine, glutamate) that neutralizes reactive oxygen species and supports liver detoxification. People stack them because aging depletes both NAD+ and glutathione simultaneously, creating a dual redox deficit.

How NAD+ Levels Change With Age

NAD+ declines roughly 50% between age 40 and age 60 in human muscle tissue, according to data from Massudi et al. (2012) published in PLOS ONE [1]. That decline correlates with reduced mitochondrial function and increased oxidative stress markers. NMN and NR both enter the NAD+ biosynthesis pathway, though at different enzymatic entry points: NR is converted to NMN by NR kinase, while NMN enters directly via the Preiss-Handler and salvage pathways.

How Glutathione Levels Change With Age

Plasma glutathione concentrations drop approximately 17% per decade after age 45, based on cross-sectional data reviewed by Sekhar et al. (2011) in the American Journal of Clinical Nutrition [2]. This depletion is driven partly by reduced synthesis of the precursor amino acids cysteine and glycine. Sekhar's group later demonstrated in a randomized controlled trial (N=8 older adults, mean age 71) that glycine and N-acetylcysteine (GlyNAC) supplementation restored glutathione levels within 24 weeks [3].

Why Combining Them Makes Biological Sense

The two systems are not independent. NAD+ fuels NADPH production via the pentose phosphate pathway. NADPH, in turn, is the electron donor that glutathione reductase uses to regenerate oxidized glutathione (GSSG) back to its active reduced form (GSH). In simple terms: more NAD+ can mean better glutathione recycling. This is a pharmacodynamic relationship, not a pharmacokinetic one, meaning the compounds do not interfere with each other's absorption, metabolism, or excretion.

Is There a Known Drug Interaction Between Glutathione and NMN or NR?

No clinically documented drug-drug or supplement-drug interaction exists between glutathione and either NMN or NR in any major interaction database as of January 2025. The Natural Medicines database rates this combination as having insufficient reliable information to conclude harm, which is categorically different from identifying a danger signal.

Pharmacokinetic Profile of NMN

Oral NMN is absorbed in the small intestine via the transporter Slc12a8 (identified in mouse intestine by Grozio et al. [4]) and converted to NMN or directly to NAD+ depending on tissue. In the first published human pharmacokinetic study by Irie et al. (2020, N=10 healthy men), a single 100 mg, 250 mg, or 500 mg oral dose raised blood NMN concentrations within 2 to 3 hours with no serious adverse events [5]. NMN is not significantly protein-bound and does not inhibit or induce cytochrome P450 enzymes, so it is unlikely to alter glutathione metabolism through pharmacokinetic pathways.

Pharmacokinetic Profile of NR

NR bioavailability data come primarily from the Trammell et al. (2016) randomized crossover study (N=12) published in Nature Communications, which showed that 1,000 mg oral NR raised whole-blood NAD+ by 2.7-fold over baseline at peak, with maximum concentrations at roughly 2.5 hours [6]. Like NMN, NR does not appear to interact with hepatic drug-metabolizing enzymes.

Pharmacokinetic Profile of Glutathione

Oral glutathione absorption has historically been considered poor because intestinal peptidases cleave it before absorption. A randomized trial by Richie et al. (2015, N=54) in the European Journal of Nutrition showed that 250 mg or 1,000 mg oral glutathione taken daily for 6 months did raise whole-blood glutathione by 17% and 29% respectively [7]. Liposomal delivery appears to improve bioavailability further, though head-to-head comparative data are limited. IV glutathione bypasses gut degradation entirely, producing more reliable plasma elevations.

Do NMN/NR and Glutathione Interact at the Cellular Level?

The short answer: they interact constructively, not harmfully. Both operate in the same redox network but at different nodes.

The NAD-NADPH-Glutathione Axis

NAD+ is reduced to NADH in glycolysis and the TCA cycle. A separate pool of NADP+ is reduced to NADPH primarily through the pentose phosphate pathway and isocitrate dehydrogenase. NADPH is the critical reductant for glutathione reductase, the enzyme that converts GSSG to GSH. Animal studies show that NAD+ precursor supplementation increases NADPH availability in hepatocytes, which in turn sustains higher GSH/GSSG ratios under oxidative stress conditions [8].

This means NMN or NR supplementation may support endogenous glutathione activity, even without exogenous glutathione supplementation. Adding exogenous glutathione on top simply provides more substrate for the same protective pathway.

Sirtuin Activation and Glutathione Gene Expression

SIRT1 and SIRT3, the NAD+-dependent deacetylases activated by rising NAD+ concentrations, regulate the transcription factor Nrf2. Nrf2 controls the expression of glutamate-cysteine ligase (GCL), the rate-limiting enzyme in glutathione synthesis. A 2019 study in Redox Biology showed that SIRT3 activation enhanced Nrf2 nuclear translocation and increased GCL expression in mouse liver cells under oxidative conditions [9]. If NMN or NR raises NAD+ enough to activate SIRT3, it could increase endogenous glutathione production independent of supplementation.

No Evidence of Antagonism

No published preclinical or clinical study has reported that glutathione reduces NAD+ levels, blocks NMN or NR absorption, or diminishes the NAD+-raising effects of either precursor. The pathways do not converge at a competitive enzymatic step.

Liver Detoxification: The Reason Many People Combine These Supplements

The liver is the primary site of both NAD+ utilization and glutathione synthesis. People undergoing metabolic detox protocols, those with non-alcoholic fatty liver disease (NAFLD), or those on hepatotoxic medications often combine NAD+ precursors with glutathione for this reason.

NAD+ and Liver Function

A 2022 randomized, double-blind trial by Yoshino et al. (N=25 postmenopausal women with prediabetes, 250 mg NMN daily for 10 weeks) published in Science demonstrated that NMN improved muscle insulin sensitivity, with no adverse liver-function signals detected [10]. Separately, animal data show that NAD+ depletion worsens NAFLD severity and that NMN or NR supplementation reduces hepatic lipid accumulation in diet-induced obese mice [11].

Glutathione and Liver Detoxification

Hepatic glutathione is central to Phase II detoxification. It conjugates reactive metabolites of drugs and environmental toxins via glutathione S-transferases. Oral glutathione supplementation at 500 mg/day for 4 months reduced serum alanine aminotransferase (ALT) in adults with NAFLD compared to placebo in a small pilot study (N=29) [12]. IV glutathione at 600 mg given before chemotherapy cycles is used off-label in some oncology centers to reduce peripheral neuropathy, though this application is separate from longevity stacking.

Combining Both for Hepatic Support

No head-to-head randomized trial has yet examined NMN or NR plus glutathione specifically for liver outcomes in humans. The mechanistic rationale is sound. Prudence suggests checking baseline liver enzymes (ALT, AST, GGT) before starting either supplement and rechecking at 90 days, particularly if doses exceed 500 mg/day for either compound.

Injectable Glutathione: Does the Route of Administration Change the Interaction Profile?

Injectable (IV or IM) glutathione raises plasma glutathione concentrations far above the range achievable orally. This matters because high-dose IV antioxidants can, in theory, interfere with oxidative stress signaling pathways that the body uses for adaptive responses.

Hormesis and the Oxidative Stress Question

Exercise produces reactive oxygen species. Those ROS act as signaling molecules that trigger mitochondrial biogenesis via PGC-1alpha. High-dose antioxidants given immediately before or after exercise have been shown in some trials to blunt these adaptive signals. A landmark study by Ristow et al. (2009, N=40) in PNAS showed that vitamins C and E supplementation blocked exercise-induced improvements in insulin sensitivity [13]. Whether IV glutathione produces similar interference is unknown, though the concern is biologically plausible.

Practical Guidance for Injectable Glutathione Users

If you receive IV or IM glutathione alongside NMN or NR supplementation, the key consideration is timing relative to exercise rather than a direct NMN/glutathione interaction. Taking NMN in the morning and scheduling IV glutathione sessions on non-exercise days reduces theoretical overlap with exercise-adaptive ROS signaling. This recommendation is based on mechanism rather than direct trial evidence.

Monitoring for IV Glutathione

IV glutathione is not FDA-approved for any indication. Its compounded use should be monitored with periodic liver function panels and renal function tests. IV doses above 1,200 mg per session have not been well-characterized in safety studies. Report any rash, bronchospasm, or injection-site reactions to your prescribing clinician immediately.

Who Should Be Cautious About This Combination?

Most healthy adults face no significant risk from combining oral NMN or NR with oral glutathione. Certain groups warrant additional attention.

People on Chemotherapy

Both NAD+ and glutathione support DNA repair and cellular survival. Oncologists have raised the theoretical concern that antioxidant supplementation may protect tumor cells from chemotherapy-induced oxidative damage. The American Cancer Society advises patients to discuss all supplements with their oncology team before starting [14]. This caution applies to glutathione, NMN, and NR individually, and even more so to combinations during active treatment.

People With G6PD Deficiency

Glucose-6-phosphate dehydrogenase (G6PD) deficiency impairs NADPH generation and therefore glutathione recycling. Supplementing with glutathione in this population is mechanistically rational but has not been formally studied. NMN or NR supplementation in G6PD deficiency is also understudied. Anyone with confirmed G6PD deficiency should consult a hematologist before starting either supplement.

Pregnant or Breastfeeding Individuals

Neither NMN, NR, nor high-dose glutathione has been studied in pregnancy. Standard supplementation safety guidelines recommend avoiding unstudied supplements during pregnancy unless the clinical benefit clearly outweighs unknown risk.

Dosing and Timing: A Practical Protocol

The following framework reflects current clinical thinking from the HealthRX medical team, based on available pharmacokinetic data and mechanistic evidence. No specific randomized trial has validated this exact combination protocol.

Morning Stack (Fasted or With a Light Meal)

• NMN: 250 mg to 500 mg orally, taken in the morning. Some clinicians prefer the fasted state based on animal data suggesting better intestinal transporter activity, though human evidence on timing is limited.
• NR: 300 mg to 500 mg can substitute for NMN or be combined with it; the two are not redundant in all tissues.
• Oral glutathione (liposomal): 250 mg to 500 mg with or without food. Liposomal formulations may be taken simultaneously with NMN without absorption interference.

Separating IV Glutathione From NMN Doses

IV glutathione sessions are typically weekly or biweekly. Because IV glutathione peaks rapidly (within 30 to 60 minutes IV) and clears within hours, there is no need to pause NMN or NR on infusion days. Continuing oral NMN or NR on IV glutathione days is reasonable given the absence of any known pharmacokinetic conflict.

Supporting Cofactors to Consider

The NAD+ biosynthesis pathway and glutathione synthesis both benefit from upstream cofactors:

• Magnesium glycinate (200 to 400 mg): cofactor for multiple NAD+-dependent enzymes.
• B vitamins (B2, B3, B6): NR and NMN metabolism requires riboflavin; B6 supports cysteine availability for glutathione synthesis.
• Glycine (1,000 to 3,000 mg): the rate-limiting amino acid for glutathione synthesis in older adults, per the GlyNAC trials by Kumar et al. [15].
• N-acetylcysteine (NAC, 600 mg): provides cysteine, the other rate-limiting glutathione precursor, and is the most evidence-backed glutathione booster available.

What the Clinical Trials Show About NMN and NR Individually

Understanding what each compound does in isolation informs expectations for the combination.

NMN Human Trial Data

The Yoshino et al. (2021) Science trial (N=25, 250 mg NMN daily for 10 weeks) remains the most cited NMN human RCT [10]. It showed improved muscle insulin sensitivity with no serious adverse events. A 2022 trial by Yi et al. (N=66, 300 mg or 600 mg NMN daily for 60 days) in GeroScience showed dose-dependent increases in blood NAD+ concentrations (P<0.001 for both doses vs. Placebo) and modest improvements in physical performance metrics [16].

NR Human Trial Data

The landmark Trammell et al. (2016) Nature Communications trial established NR's ability to raise blood NAD+ acutely [6]. A larger randomized trial by Martens et al. (2018, N=24 healthy older adults) in Nature Communications showed that 1,000 mg NR daily for 21 days raised blood NAD+ by 60% compared to baseline without significant adverse events [17]. Blood pressure showed a non-significant trend toward reduction in aortic stiffness, a finding that has not been replicated at scale.

Glutathione Trial Data in Healthy Adults

Richie et al. (2015, N=54, up to 1,000 mg oral glutathione for 6 months) reported a 17% to 29% increase in whole-blood glutathione from baseline, with no adverse safety signals and no changes in liver enzymes [7]. This is the most strong oral glutathione pharmacokinetic trial in humans to date.

Expert Perspectives on This Combination

The Endocrine Society's 2023 position statement on supplements and metabolic health notes that "evidence for most longevity supplements remains preliminary, and clinicians should encourage shared decision-making rather than blanket restriction." [18]

Dr. Rhonda Patrick, a researcher frequently cited in the longevity supplement literature, has stated publicly that she views NAD+ precursors and glutathione as complementary rather than competing interventions, given their distinct but connected roles in redox homeostasis. Her framing aligns with the mechanistic literature, though she is careful to note the absence of long-term human outcome data.

The HealthRX medical team position: oral NMN or NR combined with oral glutathione can be initiated simultaneously in healthy adults without a washout or separation period. The combination warrants monitoring only when injectable glutathione is used at doses above 600 mg per session, or when either compound is used in the setting of active liver disease, cancer treatment, or G6PD deficiency.

Monitoring Recommendations

For most adults using oral supplements in the standard dose ranges, monitoring is straightforward.

Baseline Labs Before Starting

• Complete metabolic panel (CMP) including ALT, AST, GGT, bilirubin, creatinine, BUN.
• Whole-blood NAD+ (available through specialty labs such as Jinfiniti) if tracking NAD+ response objectively.
• Plasma or whole-blood glutathione (less standardized but available through integrative medicine labs).

Follow-Up at 90 Days

• Repeat CMP. A rise in ALT above 3x the upper limit of normal (<40 IU/L at most labs, so a rise above 120 IU/L) should prompt discontinuation of both supplements and clinical evaluation.
• Reassess subjective energy, sleep quality, and exercise recovery, the outcomes most commonly reported to improve in early NMN and NR trials.

When to Stop and Seek Care

Stop both supplements and contact your clinician if you develop jaundice, significant fatigue, right upper-quadrant abdominal pain, or any new rash, particularly with IV glutathione use.